Stimulation of monocytes with immunomodulating agents can harness the immune system to
treat a long range of diseases, including cancers, infections and autoimmune diseases. To …

Aberrant T-cell activation underlies many autoimmune disorders, yet most attempts to induce
T-cell tolerance have failed. Building on previous strategies for tolerance induction that …

Autoimmune processes can be found in physiological circumstances. However, they are
quenched with properly functioning regulatory mechanisms and do not evolve into full …

Autoimmune diseases are diseases caused by the body's chronic immune responses to self-
antigens and attacks on the host's own cells, tissues and organs. The dysfunction of innate …

Relapsing-remitting patterns of many autoimmune diseases such as multiple sclerosis (MS)
are perpetuated by a recurring circuit of adaptive immune cells that amplify in secondary …

The association of autoimmune diseases with particular allellic products of the class-II major
histocompatibility complex (MHCII) region implicates the presentation of the offending self …

Immunotherapy is a promising option for cancer treatment that might cure cancer with fewer
side effects by primarily activating the host's immune system. However, the effect of …

Autoimmune diseases result from a dysfunctional immune system in which the body attacks
its own organs, tissues, cells, and macromolecules. This group of diseases consists of more …

Chemoimmunotherapy is an emerging paradigm in the clinic for treating several malignant
diseases, such as non-small cell lung cancer, breast cancer, and large B-cell lymphoma …

The function of the brain can be affected by various factors that include infection, tumor, and
stroke. The major disorders reported with altered brain function are Alzheimer's disease …